2020
DOI: 10.3390/molecules25163708
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Antiviral Evaluation of 3′-Fluoro-5′-norcarbocyclic Nucleoside Phosphonates Bearing Uracil and Cytosine as Potential Antiviral Agents

Abstract: Carbocyclic nucleoside analogues are an essential class of antiviral agents and are commonly used in the treatment of viral diseases (hepatitis B, AIDS). Recently, we reported the racemic synthesis and the anti-human immunodeficiency virus activities (HIV) of 3′-fluoro-5′-norcarbocyclic nucleoside phosphonates bearing purines as heterocyclic base. Based on these results, the corresponding racemic norcarbocyclic nucleoside phosphonates bearing pyrimidine bases were synthesized. The prepared compounds were evalu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
(12 reference statements)
0
2
0
Order By: Relevance
“…Nucleoside and nucleotide analogues with modified changes can mimic the structure of nature nucleosides and nucleotides that can be recognized by cellular or viral enzymes [ 5 , 6 ]. Many strategies (e.g., ring-opening, N -conjugation, halogenation) have been proposed to design novel nucleoside or nucleotide analogues, such as the acyclic fleximer analogues [ 7 ], propargylated purine deoxynucleosides [ 8 ], 4′-thionucleosides [ 9 ], 3′-fluoro-5′-norcarbocyclic nucleoside phosphonates [ 10 ], 4′-modified-2′-deoxy-2′-fluoro nucleosides [ 11 ], uracil-containing heterodimers [ 12 ], l-dideoxy bicyclic pyrimidine nucleoside analogues [ 13 ], and imidazo[4,5-b]pyridine nucleoside analogues [ 14 ]. In addition to the development of N -nucleoside analogues, C-nucleoside analogues could be considered because they are stably resistant against the phosphorolytic degradation caused by phosphorylases [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…Nucleoside and nucleotide analogues with modified changes can mimic the structure of nature nucleosides and nucleotides that can be recognized by cellular or viral enzymes [ 5 , 6 ]. Many strategies (e.g., ring-opening, N -conjugation, halogenation) have been proposed to design novel nucleoside or nucleotide analogues, such as the acyclic fleximer analogues [ 7 ], propargylated purine deoxynucleosides [ 8 ], 4′-thionucleosides [ 9 ], 3′-fluoro-5′-norcarbocyclic nucleoside phosphonates [ 10 ], 4′-modified-2′-deoxy-2′-fluoro nucleosides [ 11 ], uracil-containing heterodimers [ 12 ], l-dideoxy bicyclic pyrimidine nucleoside analogues [ 13 ], and imidazo[4,5-b]pyridine nucleoside analogues [ 14 ]. In addition to the development of N -nucleoside analogues, C-nucleoside analogues could be considered because they are stably resistant against the phosphorolytic degradation caused by phosphorylases [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…22,23 The uracil scaffold and its derivatives exhibit a wide range of biological activities, including anticancer agents, [24][25][26] antihypertensive agents, 27 antiallergic compounds 28 and antiviral agents. [29][30][31] Structures of some FDA-approved uracil drugs are depicted in figure 1. Moreover, dipyrimidines exhibit a broad range of pharmacological properties, such as antimicrobial, 32,33 antitumor, 34 and antiviral.…”
Section: Introductionmentioning
confidence: 99%